Found: 31
Select item for more details and to access through your institution.
Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Addition of vandetanib to pegylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A randomized phase I/II study of the AGO Study Group (AGO-OVAR 2.13)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Bio-distribution study of Reolysin® (pelareorep) through a single intravenous infusion in Sprague-Dawley rats.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1539, doi. 10.1007/s10637-013-0029-6
- By:
- Publication type:
- Article
ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1409, doi. 10.1007/s10637-013-0008-y
- By:
- Publication type:
- Article
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1587, doi. 10.1007/s10637-013-0024-y
- By:
- Publication type:
- Article
Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1399, doi. 10.1007/s10637-013-0007-z
- By:
- Publication type:
- Article
A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1568, doi. 10.1007/s10637-013-0014-0
- By:
- Publication type:
- Article
A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1592, doi. 10.1007/s10637-013-0027-8
- By:
- Publication type:
- Article
NCIC CTG IND.181: Phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1522, doi. 10.1007/s10637-013-0018-9
- By:
- Publication type:
- Article
Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1609, doi. 10.1007/s10637-013-0006-0
- By:
- Publication type:
- Article
Addition of vandetanib to pegylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A randomized phase I/II study of the AGO Study Group (AGO-OVAR 2.13).
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1499, doi. 10.1007/s10637-013-0011-3
- By:
- Publication type:
- Article
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1547, doi. 10.1007/s10637-013-0032-y
- By:
- Publication type:
- Article
Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies-results of a phase I dose-escalation study.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1487, doi. 10.1007/s10637-013-0010-4
- By:
- Publication type:
- Article
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1514, doi. 10.1007/s10637-013-0015-z
- By:
- Publication type:
- Article
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1559, doi. 10.1007/s10637-013-0034-9
- By:
- Publication type:
- Article
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1580, doi. 10.1007/s10637-013-0022-0
- By:
- Publication type:
- Article
Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1424, doi. 10.1007/s10637-013-0016-y
- By:
- Publication type:
- Article
The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers.
- Published in:
- 2013
- By:
- Publication type:
- Report
Erratum to: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1530, doi. 10.1007/s10637-013-0026-9
- By:
- Publication type:
- Article
Chemo-sensitisation of HeLa cells to Etoposide by a Benzoxazine in the absence of DNA-PK inhibition.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1466, doi. 10.1007/s10637-013-0031-z
- By:
- Publication type:
- Article
Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360).
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1444, doi. 10.1007/s10637-013-0025-x
- By:
- Publication type:
- Article
Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1458, doi. 10.1007/s10637-013-0030-0
- By:
- Publication type:
- Article
Bio-distribution study of Reolysin® (pelareorep) through a single intravenous infusion in Sprague-Dawley rats.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1476, doi. 10.1007/s10637-013-0033-x
- By:
- Publication type:
- Article
Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A gemcad study.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1573, doi. 10.1007/s10637-013-0020-2
- By:
- Publication type:
- Article
OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1436, doi. 10.1007/s10637-013-0017-x
- By:
- Publication type:
- Article
Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1602, doi. 10.1007/s10637-013-0028-7
- By:
- Publication type:
- Article
Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1505, doi. 10.1007/s10637-013-0013-1
- By:
- Publication type:
- Article
Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO).
- Published in:
- 2013
- By:
- Publication type:
- Report